OraSure Technologies | OSUR - Current Liabilities


OraSure Technologies reported $39.8M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Agilent USD 2.23B 113M Dec/2025
AngioDynamics USD 71.96M 3.68M Sep/2025
Becton, Dickinson and Co. USD 8.76B 448M Dec/2025
Bio Techne USD 140.43M 4.12M Dec/2025
Bio-Rad Laboratories USD 917M 400M Mar/2026
Bruker USD 1.28B 11.1M Dec/2025
Cerus USD 100.8M 12.37M Dec/2025
Charles River Laboratories USD 1.12B 1.57M Dec/2025
Danaher USD 7.46B 653M Mar/2026
Dentsply International USD 1.21B 136M Mar/2026
Dexcom USD 2.22B 81.3M Mar/2026
Illumina USD 1.57B 19M Mar/2026
Integra LifeSciences USD 346.85M 109.14M Mar/2026
Intuitive Surgical USD 2.51B 3.2M Mar/2026
IQVIA Holdings USD 8.33B 9M Mar/2026
Mesa Laboratories USD 54.4M 6.1M Dec/2025
Mettler Toledo International USD 1.2B 5.99M Dec/2025
Myriad Genetics USD 133.8M 14.2M Dec/2025
OraSure Technologies USD 39.8M 453K Dec/2025
Quidel USD 966.1M 198.2M Dec/2025
Repligen USD 135.83M 4.69M Dec/2025
Revvity USD 1.33B 108.5M Dec/2025
STAAR Surgical USD 68.5M 6.87M Dec/2025
Thermo Fisher Scientific USD 14.62B 568M Mar/2026
Trinity Biotech USD 34.49M 2.97M Sep/2025
Waters USD 1.24B 11.8M Dec/2025